Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.

Guo LT, Zhang XU, Kuang W, Xu H, Liu LA, Vilquin JT, Miyagoe-Suzuki Y, Takeda S, Ruegg MA, Wewer UM, Engvall E.

Neuromuscul Disord. 2003 Mar;13(3):207-15.

PMID:
12609502
2.

Merosin and congenital muscular dystrophy.

Miyagoe-Suzuki Y, Nakagawa M, Takeda S.

Microsc Res Tech. 2000 Feb 1-15;48(3-4):181-91. Review.

PMID:
10679965
3.

The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Jones KJ, Morgan G, Johnston H, Tobias V, Ouvrier RA, Wilkinson I, North KN.

J Med Genet. 2001 Oct;38(10):649-57. Review.

4.

Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse.

Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T.

Neuromuscul Disord. 1997 Jan;7(1):7-12. Review.

PMID:
9132144
5.

Animal models of muscular dystrophies.

Nonaka I.

Lab Anim Sci. 1998 Feb;48(1):8-17. Review.

PMID:
9517883
6.

The childhood muscular dystrophies: making order out of chaos.

Tsao CY, Mendell JR.

Semin Neurol. 1999;19(1):9-23. Review.

PMID:
10711985
7.

Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.

Shibuya S, Wakayama Y, Inoue M, Kojima H, Oniki H.

Med Electron Microsc. 2003 Dec;36(4):213-20. Review.

PMID:
16228654
8.

Laminins during muscle development and in muscular dystrophies.

Gullberg D, Tiger CF, Velling T.

Cell Mol Life Sci. 1999 Oct 30;56(5-6):442-60. Review.

PMID:
11212297
9.

Merosin/laminin-2 and muscular dystrophy.

Wewer UM, Engvall E.

Neuromuscul Disord. 1996 Dec;6(6):409-18. Review.

PMID:
9027848
10.

Dysferlin and muscular dystrophy.

Bushby KM.

Acta Neurol Belg. 2000 Sep;100(3):142-5. Review.

PMID:
11098285
11.

Laminin-╬▒2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.

Durbeej M.

Curr Top Membr. 2015;76:31-60. doi: 10.1016/bs.ctm.2015.05.002. Review.

PMID:
26610911
12.

The functions of laminins: lessons from in vivo studies.

Ryan MC, Christiano AM, Engvall E, Wewer UM, Miner JH, Sanes JR, Burgeson RE.

Matrix Biol. 1996 Dec;15(6):369-81. Review.

PMID:
9049976
13.

Muscular dystrophy: centronucleation may reflect a compensatory activation of defective myonuclei.

Totsuka T, Watanabe K, Uramoto I, Sakuma K, Mizutani T.

J Biomed Sci. 1998;5(1):54-61. Review.

PMID:
9570514
14.

Laminin alpha2 deficiency-associated muscular dystrophy in a Maine coon cat.

Poncelet L, R├ęsibois A, Engvall E, Shelton GD.

J Small Anim Pract. 2003 Dec;44(12):550-2. Review.

PMID:
14692554
15.

Immunocytochemical analysis of human muscular dystrophy.

Sewry CA.

Microsc Res Tech. 2000 Feb 1-15;48(3-4):142-54. Review.

PMID:
10679962
16.

Congenital muscular dystrophies.

Arahata K, Ishii H, Hayashi YK.

Curr Opin Neurol. 1995 Oct;8(5):385-90. Review.

PMID:
8542045
17.
18.

Structure and function of basement membranes.

Engvall E.

Int J Dev Biol. 1995 Oct;39(5):781-7. Review.

19.

Congenital muscular dystrophy: molecular and cellular aspects.

Jimenez-Mallebrera C, Brown SC, Sewry CA, Muntoni F.

Cell Mol Life Sci. 2005 Apr;62(7-8):809-23. Review.

PMID:
15868406
20.

Animal models for genetic neuromuscular diseases.

Vainzof M, Ayub-Guerrieri D, Onofre PC, Martins PC, Lopes VF, Zilberztajn D, Maia LS, Sell K, Yamamoto LU.

J Mol Neurosci. 2008 Mar;34(3):241-8. doi: 10.1007/s12031-007-9023-9. Epub 2008 Jan 18. Review.

PMID:
18202836

Supplemental Content

Support Center